Stock Analysts

Neurocrine Gives Ingrezza Sales View, Updates on Pipeline

Neurocrine Biosciences, Inc. NBIX provided preliminary sales guidance for Ingrezza pertaining to the fourth quarter of 2018 and the full year along with an update on its pipeline candidates. 2018 Preliminary Results Based on unaudited financial results, Neurocrine expects Ingrezza sales for the full year to be approximately $409 million, reflecting a staggering increase of 250.8% from the prior-year level […]

Mergers & Acquisitions

Canyon Partners Sends Letter to Rowan Companies plc Board of Directors

Canyon Partners Sends Letter to Rowan Companies plc Board of Directors PR Newswire LOS ANGELES, Jan. 7, 2019 LOS ANGELES , Jan. 7, 2019 /PRNewswire/ — Canyon Capital Advisors LLC (together with certain of its affiliates, “Canyon”) is the investment advisor to funds and accounts that hold over 8 million shares, or approximately 6.3%, of the outstanding ordinary shares of Rowan Companies plc (“Rowan” or the “Company”) (NYSE: RDC) […]

Mergers & Acquisitions

Huron Capital Completes Equity Investment in WD Lab Grown Diamonds

Huron Capital Completes Equity Investment in WD Lab Grown Diamonds Company is Poised for Accelerated Growth as Demand for Lab-grown Diamonds Continues to Rise PR Newswire DETROIT, Jan. 7, 2019 DETROIT , Jan. 7, 2019 /PRNewswire/ — Leading middle-market private equity firm Huron Capital announced today it has made a significant equity investment in WD Lab Grown Diamonds (“WD” or the “Company”). […]